Form 8-K - Current report:
SEC Accession No. 0001453687-24-000110
Filing Date
2024-09-26
Accepted
2024-09-26 07:02:24
Documents
13
Period of Report
2024-09-25
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K rnac-20240925.htm   iXBRL 8-K 27284
  Complete submission text file 0001453687-24-000110.txt   152906

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rnac-20240925.xsd EX-101.SCH 1981
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rnac-20240925_lab.xml EX-101.LAB 22788
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rnac-20240925_pre.xml EX-101.PRE 13107
15 EXTRACTED XBRL INSTANCE DOCUMENT rnac-20240925_htm.xml XML 2728
Mailing Address 704 QUINCE ORCHARD RD GAITHERSBURG MD 20878
Business Address 704 QUINCE ORCHARD RD GAITHERSBURG MD 20878 617-923-1400
Cartesian Therapeutics, Inc. (Filer) CIK: 0001453687 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37798 | Film No.: 241326168
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)